Skip to content

The Role of Uncertainty in Anxiety, OCD, and Trauma.

Delineating the Role of Uncertainty Tolerance in Anxiety-, Obsessive Compulsive-, and Posttraumatic Stress-disorders - Delineating the Role of Uncertainty Tolerance in Anxiety-, Obsessive Compulsive-, and posttraumatic stressdisorders

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58308
Enrollment
100
Registered
2025-06-10
Start date
2025-11-30
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety-, obsessive compulsive-, trauma-related symptoms. Anxiety symptoms

Interventions

Er wordt geen product/interventie onderzocht.&nbsp

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: The participant meets the diagnostic criteria for at least one anxiety disorder as listed in the DSM-5 (American Psychiatric Association, 2013) or a related condition, specifically posttraumatic stress disorder (PTSD) or obsessive-compulsive disorder (OCD), as determined by the treating clinician.The participant is engaged in or seeking treatment at Mondriaan for this/these disorder(s).The participant has provided written informed consent, confirming their understanding of the study's objectives, procedures, and willingness to participate.The participant has adequate proficiency in Dutch to understand task instructions and undergo treatment.The participant has access to a computer (desktop or laptop) with an internet connection and sufficient proficiency in using it (i.e., to open computertasks via email and complete VAS scales).The participant is willing to be available for online follow-up for up to 6 months after initial participation. The participant is at least 18 years old. The participant meets none of the exclusion criteria.   

Exclusion criteria

Exclusion criteria: Current substance abuse (e.g., excessive use of drugs or alcohol).Current florid psychosis.Severe visual impairments that prevent proper recognition of task stimuli (e.g., legal blindness).

Design outcomes

Primary

MeasureTime frame
The primary outcomes for this study are baseline anxiety levels (LWASQ), baseline IU scores, and expectancy and avoidance ratings during the EAG tasks. 

Secondary

MeasureTime frame
The secondary outcomes for this study are three- and six-month follow-up anxiety levels (LWASQ) and symptomatic recovery levels (OQ-45)

Countries

Netherlands

Contacts

Public ContactC.J. Brouwer

Universiteit Maastricht

cj.brouwer@maastrichtuniversity.nl0612262856

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Feb 3, 2026